Department of Biotechnology, Beijing Institute of Radiation Medicine, No. 27 Taiping Road, Beijing, P. R. China.
Planta Med. 2012 Apr;78(6):611-6. doi: 10.1055/s-0031-1298223. Epub 2012 Feb 3.
Five new steroidal glycosides, timosaponin J ( 1), timosaponin K ( 2), (25 S)-karatavioside C ( 5), timosaponin L ( 6), and (25 S)-officinalisnin-I ( 8), together with eight known steroidal saponins, timosaponin E (1) ( 3), purpureagitosid ( 4), timosaponin BII ( 7), timosaponin B III ( 9), anemarrhenasaponin I ( 10), anemarrhenasaponin III ( 11), anemarrhenasaponin A (2) ( 12), and timosaponin A III ( 13), were isolated from the rhizomes of Anemarrhena asphodeloides. Their structures were elucidated on the basis of spectroscopic and chemical evidence. The aglycones of compounds 1 and 2 are new aglycones. Compounds 1- 13 were evaluated for their platelet aggregation activities, and compound 13 exhibited the strongest inhibitory effect on adenosine diphosphate (ADP)-induced platelet aggregation.
从知母根茎中分离得到了五个新甾体糖苷,分别为知母皂苷 J(1)、知母皂苷 K(2)、(25S)-karatavioside C(5)、知母皂苷 L(6)和(25S)-officinalisnin-I(8),以及八个已知甾体皂苷,分别为知母皂苷 E(1)(3)、紫菀糖苷(4)、知母皂苷 BII(7)、知母皂苷 BIII(9)、菝葜皂苷 I(10)、菝葜皂苷 III(11)、菝葜皂苷 A(2)(12)和知母皂苷 AIII(13)。这些化合物的结构是通过光谱和化学证据确定的。化合物 1 和 2 的糖苷配基是新的糖苷配基。对化合物 1-13 进行了血小板聚集活性评价,化合物 13 对二磷酸腺苷(ADP)诱导的血小板聚集有最强的抑制作用。